Neonc Technologies Holdings, Inc.
NASDAQ:NTHIBiotechnology
+$0.14 today
- Market cap
- $120.02M
- Beta
- 0.29
- P/E (TTM)
- -3.0
- EPS (TTM)
- -$1.66
Volume 0.27M
Average 0.08M
NTHI Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Neonc Technologies Holdings, Inc.NASDAQ: NTHI
Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Financing cash flow declines year over year
Q1 FY2026 financing cash flow of $7.07M fell 35.9% year over year. Sequentially, it rose 168.2% from the prior quarter.
Context
- Financing cash flow amounted to 52157.5% of revenue in FY2025.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 20.86M USD
- Year-over-year change
- —
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 20.86M | — |
Financing Cash Flow vs competitors
How NTHI compares with its peers on the latest reported figures
No competitor Financing Cash Flow figures are available to compare.
Cash Flow Statement
Neonc Technologies Holdings, Inc.
NASDAQ:NTHI
Intrinsic Alpha fair value
Locked
Current Price
$4.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.